Top of page
Global Site Navigation

Centre of Excellence for Alzheimer's Disease Research and Care

Local Section Navigation

Help us improve our content by rating this page.

Page rating system

Please tell us why your content rating for this page is low.
If you'd rather not, just click Submit.

You are here:
ECU is currently converting this web content to a more mobile friendly format. If you find the content below is not formatting correctly during this transition please view on desktop browser.
Main Content

Publications

The Centre for Alzheimer's Disease Research and Care has an active research program, below is a list of our publications from the past five years.

2010

  • Newman, M., Wilson, L., Camp, E., Verdile, G., Martins, R. and Lardelli, M. A zebrafish melanophore model of amyloid beta toxicity. Zebrafish (2010) Vol 7 No 2, 155-159.
  • Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain. 2010 Aug 25. [Epub ahead of print]
  • Sharman MJ, Morici M, Hone E, Berger T, Taddei K, Martins IJ, Lim WL, Singh S, Wenk MR, Ghiso J, Buxbaum JD, Gandy S, Martins RN. APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice. J Alzheimers Dis. 2010 Jan 1;21(2):403-9.PMID: 20555142 [PubMed - in process]
  • Barron, A., Verdile, G., Taddei K., Bates K.A., and Martins, R.N. (2010). Effect of chronic hCG adminstration on Alzheimer’s-related cognition and Abeta accumulation in PS1KI mice. Endocrinology, in press, Accepted, 14/08/10.
  • Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D; AIBL research group. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2010 May; 6(3):291-6. PMID: 20451879 [PubMed - indexed for MEDLINE]
  • Jenner AM, Lim WL, Ng MP, Wenk MR, Shui G, Sharman MJ, Gandy SE, Martins RN. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. Neuroscience. 2010 Aug 11;169(1):109-15. Epub 2010 Apr 21. PMID: 20416362 [PubMed - in process]
  • Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010 Mar; 67(3):317-24.
  • Kajiwara Y, Franciosi S, Takahashi N, Krug L, Schmeidler J, Taddei K, Haroutunian V, Fried U, Ehrlich M, Martins RN, Gandy S, Buxbaum JD. Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease. Mol Neurodegener. 2010 Jan 14; 5:1.
  • Sharman MJ, Shui G, Fernandis AZ, Lim WL, Berger T, Hone E, Taddei K, Martins IJ, Ghiso J, Buxbaum JD, Gandy S, Wenk MR, Martins RN. Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry. J Alzheimers Dis. 2010 Apr; 20(1):105-11.
  • Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O; AIBL Research Group. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 2010 Jan 12; 74(2):121-7.
  • Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem. 2009 Dec; 111(6):1275-308. Review.
  • Lui JK, Laws SM, Qiao-Xin Li, Villemagne V, Ames D, Brown B, Bush AI, DeRuyck K, Dromey J, Ellis KA, Faux NG, Fostr J, Fowler C, Gupta V, Hudson P, Laughton K, Masters CL, Pertile K, Rembach A, rimajova M, Rodrigues M, Rowe C, Rumble R, Szoeke C, Taddei K, Taddei T, Trounsen B, Ward, V, Martins RN. Plasma amyloid beta as a biomarker in Alzheimer’s disease: The AIBL Study of Ageing. Journal of Alzheimer’s Disease Accepted 18.02.2010.
  •  Rodrigues MA, Foster JK, Verdile G, Joesbury K, Prince R, Devine A. Mehta P, Beilby J. Martins RN. Predicting memory decline as a risk factor for Alzheimer’s disease in older post-menopausal women: quod erat demonstrandum? Int. Psychogeratr. (2010) Mar: 22(2) 332-5.

2009

  • Ian J. Martins, Tamar Berger, Matthew J. Sharman, Giuseppe Verdile, Stephanie J. Fuller and Ralph N. Martins; Cholesterol Metabolism and Transport in the Pathogenesis of Alzheimers disease, Journal of Neurochemistry, (2009) 111(6) 1275-308.
  • Sudarsan Krishnaswamy, Giuseppe Verdile, David Groth, Limbikani Kaneyenda and Ralph N Martins; The structure and function of Alzheimers gamma secretase enzyme complex, Critical Reviews in Clinical Laboratory Sciences, 2009 46(5-6):282-301.
  • Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O and the AIBL Research Group. Aβ burden in the temporal neocortex is related to hippocampal atrophy in non-demented elderly. Neurology, (In Press).
  • Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho Lap, Fraswer P, Westaway D, Hyslop P StG, Martins RN, Buxbaum JD, Pasinetti GM, Dicksterin DL, Hof PR, Ehrlich ME, Gandy S. Dietry composition modulates brain mass and solubilizable A levels in a mouse model of aggressive Alsheimer’s amyloid pathology. Molecular Neurodegenration (2009) 4:40.
  • Chen M, Martins RN, Lardelli M. complex splicing and neural expression of duplicated tau genes in Zebrafish embryos. Journal of Alzheimer’s Disease. (2009) 18(2)305-17.
  • Hata S. Fujishige S. Araki Y. Kato N. Araseki M. Nishimura M. Hatmann D, Saftig P, Fahrenholz, F, Taniguchi M, Katsuya U, Akatsu H, Martins RN, Yamamoto K, Maeda M, Yamamoto T, Nakaya T, Gandy S, Suzuki T. Alcadein cleavages by amyloid B-Precursor Protein (APP) α- and γ-Secretases generate small peptides, p3-Alcs, indicating Alzheimer’s disease-related γ-secretase dysfunction. Journal of Biological Chemistry. 2009 Vol 284 No. 52, 36024-36033.
  • Sohrabi HR, Bates KA, Rodrigues M. Taddei K, Martins G, Laws SM, Lautenschlager NT, Dhaliwal SS, Foster JK, Martins RN, The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Ee4 carriers and non-carriers? Journal of Alzheimer’s disease, (2009) 17(1):69-79.
  •  Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IA. Aβ aggregation and possible implication in Alzheimer’s disease pathogenesis. Journal of Cellular and Molecular Medicine. (2009) 13(3)412-21.
  • Foster JK, Verdile G, Bates KA, Martins RN, Immunization in Alzheimer’s disease: naïve hope or realistic clinical potential? Molecular Psychiatry (2009) 14:239-251
  • Bates KA, Verdile G. Q-X Li, Ames D, Hudson P, Masters CL and Martins RN. Clearance mechanisms of Alzheimer’s amyloid-β peptide: implications for therapeutic design and diagnostic tests. Feature Review Molecular Psychiatry (2009) 14:469-486.
  • Barron A.M., Cake M., Verdile G., and Martins RN. Ovariectomy and 17b-estradiol replacement do not alter beta amyloid levels in sheep brain. Endocrinology, (2009) 150(7):3228-36</li>
  • Sohrabi HR, Bates KA, Rodrigues M, Taddei K, Laws SM, Lautenschlager NT, Dhaliwal SS, Johnston ANB, Mackay-Sim A, Foster JK, Martins RN. Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. Journal of Alzheimer’s Disease (2009) 17(1): 135-42.
  • Bates K, Hamid R, Sohrabi H, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager N. Mastaglia F, Laws S, Gandy SE, & Martins RN. Association of Cardiovascular Factors & Alzheimer’s Disease Plasma Amyloid-β Protein in Subjective Memory Complainers. Journal of Alzheimer’s Disease (2009) Mar 56 E-Pub ahead of print.
  • Taddei K, Laws SM, Verdile G, Munns S, D’Costa K, Harvey AR, Martins IJ, Hill F, Levy C, Shaw JE. & Martins RN. Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotxicity. Neurobiology of Aging (2009) E-Pub ahead of print.
  • Nornes S, Newman M, Wells S, Verdile G, Martins RN & Lardelli M. Independent and co-opertive action of Psen2 with Psen1 in Zebrafish embryos. Esp. Cell Res (2009) Accepted June 26 (Epub ahead of print)
  • Ellis KA, Bush AI,Darby D, De Fazio D, Foster J, Hudson P, Lauatenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike Rowe, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D: The AIBL Reserch Group. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease INT Psychogeriatr. 2009 May 27:1-16 (Epub ahead of print).
  • Drummond ES, Harvey AR, Martins RB. Androgens and Alzheimer’s disease. Curr Opin Endocrinol Diabetes Obes. 2009 June 16 (3): 254-9 Review.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Clinical epidemiology and in-patient hospital use in the last year of life (1990-2005) of 29 884 Western Australians with dementia Journal of Alzheimer's Disease 2009; 17: 399-407.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Linkage of hospital and death records increased identification of dementia cases and death rate estimates Neuroepidemiology 2009; 32 (1): 61-69.

2008

  • Hsien W.Chan, Tianbing Liu, Giuseppe Verdile, Glenda Bishop, Ryan J Haasl, Mark A Smith, George Perry, Ralph N Martins and Craig S Atwood. Copper Induces Apoptosis of Neuroblastoma Cells via Post-translatinal Regulation of the Expression of Bcl-2-family Proteins and the txj Mouse is a better Model of Hepatic than Brain Cu Toxicity. Int J Clin Exp Med (2008) 1:76-88.
  • Miklossy J., and Martins RN. Chronic Inflammation and Amyloidgenesis in Alzheimer’s Disease: The emerging Role of Infection. Journal of Alzheimer’s Disease. (2008) 13(4) 357.
  • Maczurek A, Hager K, Kenklies M, Sharman M, Martins RN, Engel J, Carlson DA, Munch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease. Advanced Drug Delivery Reviews (2008) 60:1463-1470.
  • Bates, K.A., Sohrabi, H. R., Rodrigues, M., Beilby, J., Dhaliwal, S.S., Taddei, K., Criddle A., Wraith, M., Howard, M., Martins, G., Paton, A., Mehta, P., Foster, J. K., Martins, I. J., Lautenschlager, N. T., Mastaglia, F., Laws, S. M. and Martins, R. N. “Relationship between cardiovascular disease risk factors and Alzheimer’s disease Aβ protein in subjective memory complainers”. Journal of Alzheimer’s Disease, accepted December 2008.
  • Verdile G and Martins RN. The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism. In Hogervorst, Henderson, Gibbs & Brinton (Eds.), Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies. Cambridge University Press, Shaftesbury Road, Cambridge CB2 8RU, UK, 2008 in press
  • Barron, A.M., Taddei, K., Verdile, G. & Martins, R.N. Time and dose dependent effects of human chorionic gonadotropin on APP processing and beta amyloid levels in the PS1M146V mouse model of Alzheimers disease. Alzheimer's and Dementia. 2008 4(4) S1:T347
  • Bruce DG, Davis WA, Casey G, Starkstein S, Clarnette R, Almeida OA, Davis TME. Predictors of cognitive decline in older people with diabetes. Diabetes Care 2008; 31:2103-2107.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Linkage of hospital and death records increased identification of dementia cases and death rate estimates. Neuroepidemiology 2009; 32: 61-69.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Clinical epidemiology and in-patient hospital use in the last year of life (1990-2005) of 29,884 Western Australians with dementia. Journal of Alzheimer’s Disease
  • Rosenwax LK, McNamara B, Zilkens RR. A population-based retrospective cohort study comparing care for Western Australians with and without Alzheimer's disease in the last year of life. Health and Social Care in the Community 2008; 17 (1): 36-44.
  • Panegyres PK, McCarthy M, Campbell A, Lenzo N, Fallon M, Thompson J. 2008. Correlative studies of structural and functional imaging in primary progressive aphasia. Am J Alzheimers Dis Other Demen. 23(2):184-91. Epub 2008 Jan 11
  • Almeida O, Garrido G, Beer C, Lautenchlager NT, Arnolda L, Lenzo NP, Campbell A, Flicker L. 2008. Myocardial infarction is associated with regional grey matter volume loss: implications for cognitive function and behaviour. Intern Med J. 2008 Jul;38(7):599-606.
  • Auret, K., Toye, C., Goucke, R., Kristjanson, L. J., Bruce, D., & Schug, S. (2008). Development and testing of a modified version of the Brief Pain Inventory (Cleeland, 1989) for use in residential aged care facilities.Journal of the American Geriatrics Society, 52(2), 301-306.
  • McConigley, R., Toye, C., Goucke, R., & Kristjanson, L. J. (2008). Developing Recommendations for Implementing the Australian Pain Society’s Pain Management Strategies in Residential Aged Care. Australasian Journal on Ageing, 27, (1), 45-49.
  • Dalton, P.D., Harvey, A.R., Oudega, M. and Plant, G.W. (2008) Tissue engineering of the nervous system, In: Tissue Engineering. C van Blitterswijk, P Thomsen, A Lindahl, J Hubbell, D Williams, R Cancellah, J de Bruijn, J Sohier (Eds.), Academic Press Series in Biomedical Engineering, pp. 611-647.
  • Lee, J-P., Tsai, D.J., Park, K.I., Harvey, A.R. and Snyder, E.Y. (2009) The dynamics of long term transgene expression in engrafted neural stem cells. J Comp. Neurol., (in press Oct 2008).
  • Foster JK, Verdile G, Bates KA, Martins RN. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential? Molecular Psychiatry. 2008 Oct 28. [Epub ahead of print]
  • Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Molecular Psychiatry. 2008 Sep 16. [Epub ahead of print]
  • Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G, Howard M, de Ruyck K, Bates K, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. Journal of Alzheimer’s Disease 2008 Sep;15(1):129-37.
  • Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation. 2008 Aug 20;5:36.
  • Rimajova M., Lenzo N.P., Bates K.A., Campbell A., Dhaliwal S.S., McCarthy M., Rodrigues M.A., Rowe C., Foster J.K., Martins R.N. (2008) Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEε4 carriers in the Australian population. Journal of Alzheimer’s Disease. 13, 137-146.
  • Sunram-Lea SI, Dewhurst SA, Foster JK (2008) The effect of glucose administration on the recollection and familiarity components of recognition memory. Biological Psychology, 77, 69-75.
  • Verdile G, Yeap BB, Clarnette RM, Dhaliwal S, Burkhardt MS, Chubb SAP, De Ruyck K, Rodrigues M, Mehta PD, Foster JK, Bruce DG, Martins, RN (2008) Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. Journal of Alzheimer’s Disease, 14, 201-208.
  • Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, Almeida OP, Davis TME (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia, 51, 241-248.
  • Rodrigues, M.A., Verdile G., Foster J.K., Hogervorst E., Joesbury K., Dhaliwal S., Corder E.H, Laws, S.M., Hone E., Prince, R., Devine A., Mehta, P., Beilby J., Atwood C.S., Martins, R.N. (2008) Gonadotropins and cognition in older women. Journal of Alzheimer’s Disease, 13, 267-274.
  • Foster, J.K., Smith, M.A. & van Eekelen, A. (In Press) Cognitive Science of Memory: Neurochemistry is Important Too. Trends in Cognitive Sciences.
  • De Silva R, Disanayaka S, De Zoysa N, Sanjeewanie N, Somaratne S, Foster JK, Srikanth S, Kathriarachchi S, Martins R (Accepted) Prevalence of cognitive impairment in elders' homes in Sri Lanka. International Journal of Geriatric Psychiatry.
  • Sohrabi, Hamid R, Bates, Kristyn A., Rodrigues, Mark, Taddei, Kevin, Martins, Georgia1, Laws, Simon M, Lautenschlager, Nicola T, Dhaliwal, Satvinder S, Foster, Jonathan K, Martins, Ralph N * The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein E4 carriers and non-carriers? Journal of Alzheimer’s Disease (In Press)
  • Sohrabi, Hamid R; Bates, Kristyn A; Rodrigues, Mark; Taddei, Kevin; Laws, Simon M; Lautenschlager, Nicola T; Dhaliwal, Satvinder S; Johnston, Amy N.B; Mackay-Sim, Alan; Foster, Jonathan K.; Martins,
    Ralph N. Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. Journal of Alzheimer’s Disease (In Press)
  • Foster J.K., Sohrabi H., Verdile G., and Martins R.N. (2008). Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatics, 20:853-855
  • Chan H.W., Liu T.,Verdile G, Bishop G, Haas R.J., Smith M.A., Perry G., Martins R.N. and Atwood C.S. (2008). Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the txJ Mouse is a Better Model of Hepatic than Brain Cu Toxicity. Int J Clin Exp Med, 1: 76-88.
  • Taddei K.;Laws, S.M.,Verdile G., Munns S., D'Costa K., Harvey A.R.,;Martins I.J., Hill, F., Levy E., Shaw J.E., and Martins R.N. (2008). Novel phage peptides attenuate amyloid-beta 42 catalysed hydrogen peroxide production and associated neurotoxicity. Neurobiology of Aging, in press, Accepted 31/3/08. [Epub ahead of print]
  • Verdile G and Martins RN (2008). Alzheimer’s Disease: a Research update from WA. Women in Science Enquiry Network (WISENET ) Journal 78: 7-10
  • Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian-Sarlissian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging. 2008 Oct 16. [Epub ahead of print]
  • Urosevic N, Martins RN. Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis. 2008 May;13(4):421-35. Review. PMID: 18487850 [PubMed - indexed for MEDLINE]

2007

  • Kristjanson, L. J., Walton, J., & Toye, C. (2007). Palliative Care for the Aged Care Community: An Australian Perspective. In Morse, C. (Ed). The Art of Ageing in a Global Community: Lessons from Three Nations.New York: Baywood.
  • Nornes S, Newman M, Verdile G, Wells S, Stoick-Cooper C, Tucker B, Frederich-Sleptsova I, Martins R and Michael Lardelli. (2007). Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Human Molecular Genetics, 17: 402-412
  • Barron A, Taddei K, Verdile G, and Martins RN (2007). Human chorionic gonadotropin increases exploratory behaviour and impairs episodic memory in PS1M146V mice. Neuroscience Research 58: Supplement 1, S62
  • Verdile G, Gandy SE and Martins RN. (2007) The role of presenilin and it interacting proteins in the biogenesis of Alzheimer’s beta amyloid. Neurochemical Research 32: 609-623
  • Fuller SJ. Tan RS. Martins RN. Androgens in the Etiology of Alzheimer’s Disease in Aging Men and Possible Therapeutic Interventions. Journal of Alzheimer’s Disease (2007) 12:129-142.
  • McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: A putative marker of an ongoing inflammatory process. (2007) Apr; 42(4):355-63.
  • Foster J.K., Sohrabi H., Verdile G., and Martins R.N.. Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatics, doi:10.1017/S1041610208006807 (2007)
  • Rodrigues, M.A., Verdile G., Foster J.K., Hogervorst E., Joesbury K., Dhaliwal S., Corder E.H, Laws, S.M., Hone E., Prince, R., Devine A., Mehta, P., Beilby J., Atwood C.S., Martins, R.N. Gonadotropins and Cognition in Older Women. Journal of Alzheimer’s Disease (2007)
  • Rimajova M., Lenzo N.P., Bates K.A., Campbell A., Dhaliwal S.S., McCarthy M., Rodrigues M.A., Rowe C., Foster J.K., Martins R.N. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEε4 carriers in the Australian population. Journal of Alzheimer’s Disease (2007)
  • Verdile G, Gandy SE, Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochem Res. 2007 Apr-May; 32(4-5):609-23. Epub 2006 Aug 31. Review. PMID: 16944319
  • Flicker L, Martins RN, Thomas J, Acres J, Taddei K, Vasikaran SD, Norman P, Jamrozik K, Almeida OP. B-vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging 2008 29:303-305.

2006

  • Barron AM, Verdile G. Martins RN, the role of gonadotropins in Alzheimer’s disease: potential neurodegenerative mechanisms. Endocrine (2006) Apr 29; 29(2):257-70.
  • Barron A, Verdile G and Martins RN. Gonadotropins: potential targets for preventative and therapeutic interventions in Alzheimer’s disease. Future Medicine (2006) 1(2) 189-202.
  • Martins IJ, Hone E, Foster J, Sünram-Lea S, Gnjec A, Fuller SJ, Nolan D, Gandy, SE and Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease. Molecular Psychiatry (2006) 11, 721-736 (online)
  • Barron AM, Verdile G. and Martins RN. The role of gonadotropins in Alzheimer’s disease: potential neurodegenerative mechanisms. Endocrine (2006) (2):257-70.
  • Bates KA, Martins RN, and Harvey AR. Oxidative stress in a rat model of chronic gliosis. Neurobiol Aging. (2006) June 22(e-publication ahead of print).
  • Burkhardt MS, Foster JK, Clarnette RM, Chub SAP, Bruce DG, Drummond PD, Martins RN and Yeap BB. Interaction between Testosterone and Apolipoprotein E e4 Status on Cognition in Healthy Older Men. The Journal of Endocrinology & Metabolism. (2006) 91(3):1168-1172.
  • House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R. Quantitative MR imagining R2 relaxometry in elderly participants reporting memory loss. American Journal Neuroradiology. (2006) (2):430-9.
  • Verdile G, Gandy SE and Martins RN. (2006) The role of presenilin and it interacting proteins in the biogenesis of Alzheimer’s beta amyloid. Neurochemical Research Aug 31 [e-publication ahead of print]
  • Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, Bickeboller H, Wagenpfeil S, Mueller J, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Muller U, Illig T, Heun R, Egensperger R, Schlegel J, Forstl H, Martins RN, Geman Sib-Pair Study Group, Kurz A. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer’s disease. Human Molecular Genetics (2006) (15) 2446-2456.
  • Barron AM, Fuller SJ, Verdile G, Martins RN. Reproductive hormones modulate oxidative Stress in Alzheimer’s disease. Antioxid. Redox signal. (2006) Nov 8(11-12):2047-2059
  • Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IRA, Martins RN, Krok JBJ, Halliday GM, Kril J, Schofield PR, Mann DMA, Hutton M. Mutations in progranulin ecxplain atypical phenotyres with variants in MAPT. Brain (2006) 129: 3124-3126.
  • Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins RN, Reiss K, Darbvinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer’s type changes induced by Correlia spirochetes. Neurobiology of Aging 2006) 27: 228-236.
  • Flicker L, Martins RN, Thomas J, Psych JA, Taddei K, Vasikaran SD, Norman P, Jamrozik K, Almeida OP. B-vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging (2006) Nov. 17 [Epub ahead of print]
  • Butterfield, DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease: An Initial assessment. Journal of Alzheimer’s Disease. 2006 10(4):391-7.
  • McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: A putative marker of an ongoing inflammatory process. Exp. Gerontology (2006) Nov. 29 [EPub ahead of print]
  • Bradley, C.K., Takano, E.A., Hall, M.A., Göthert, J.R., Harvey, A.R., Begley, C.G. and van Eekelan, J.A.M. (2006) The essential hematopoietic transcription factor SCL is also critical for neuronal development. Eur. J. Neurosci., 23:1677-1689.
  • Harvey, A.R., Hu, Y., Leaver, S.G., Mellough, C.B., Park, K., Verhaagen, J., Plant, G.W. and Cui, Q. (2006) Gene therapy and transplantation in CNS repair: the visual system. Prog. Retin. Eye Res., 25: 449-489.
  • Harvey, A.R. and Plant, G.W. (2006) Olfactory ensheathing glia and spinal cord injury: basic mechanisms to transplantation. Future Neurol., 1: 453-463.
  •  Leaver, S.G., Cui, Q, Bernard, O. and Harvey, A.R. (2006) Cooperative effects of Bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice. Eur. J. Neurosci., 24: 3323-3332.
  • Leaver, S.G., Cui, Q., Plant, G.W., Arulpragasam, A., Hisheh, S., Verhaagen, J. and Harvey, A.R. (2006) AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther., 13: 1328-1341
  • Leaver, S.G., Harvey, A.R. and Plant, G.W. (2006) Adult olfactory ensheathing glia promote the regeneration of adult retinal ganglion cells axons in vitro. Glia, 53: 467-476.<</li>
  • Spalding, K.L., Cui, Q., Dharmarajan, A.M. and Harvey, A.R. (2006) Injury-induced retinal ganglion cell loss in the neonatal rat retina. In: Retinal Degenerative Diseases, Joe G. Hollyfield, Robert E. Anderson, and Matthew M. LaVail (Eds), Springer, New York, NY, Adv. Exp. Med. Biol., 572: 447-451.
  • Taaffe DR, Galvão, D.A., Sharman JE Coombes JF. Reduced central blood pressure in older adults following progressive resistance training. Journal of Human Hypertension. 21:96-98, 2007.
  • Galvão D.A., Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan M.R. Suzuki K, Yamaya K., & Newton R.U. Resistance training and reduction of treatment side-effects in prostate cancer patients. Medicine and Science in Sports and Exercise. 2045-2052, 2006.<</li>
  • Galvão, D.A., Newton R.U. and Taaffe D.R. Does sex affect the muscle strength and regional lean tissue mass response to resistance training in older adults? International Journal of Sport and Health Science. 4:36-43, 2006.

Book chapters

  • Barron AM., Verdile G. and Martins RN (2008). The Role of Luteinizing Hormone in Alzheimer’s Disease. In Gonadal and nongonadal actions of Gonadotropinsn pp 275-290. Narosa Publishing House Pvt. Ltd, Delhi, India.
  • Verdile G andMartins RN (2008). Molecular Genetics of Alzheimer’s Disease. In Wildenauer D (ed) Molecular Biology of Neuropsychiatric Disorders pp 231-278. Springer-Verlag, Berlin Heidelberg.
  •  Kristjanson, L. J., Walton, J., & Toye, C. (2007). Palliative Care for the Aged Care Community: An Australian Perspective. In Morse, C. (Ed). The Art of Ageing in a Global Community: Lessons from Three Nations.New York: Baywood.
Skip to top of page